In the present study, we evaluated PTX3 tissue expression and serum levels as biomarkers of clear cell renal cell carcinoma (ccRCC) and analyzed the possible role of complement system activation on tumor site. Here, PTX3 is linked to nonpapillary renal cell carcinoma.